|
DNAJC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.727790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.367000E-01 |
| Normal-vs-Stage2 |
9.528800E-01 |
| Normal-vs-Stage3 |
1.085980E-01 |
| Normal-vs-Stage4 |
7.937700E-03 |
| Stage1-vs-Stage2 |
7.422800E-01 |
| Stage1-vs-Stage3 |
1.543990E-01 |
| Stage1-vs-Stage4 |
6.424700E-03 |
| Stage2-vs-Stage3 |
2.357800E-01 |
| Stage2-vs-Stage4 |
6.467500E-02 |
| Stage3-vs-Stage4 |
3.061000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.954400E-01 |
| Normal-vs-AfricanAmerican |
2.03819999999855E-05 |
| Normal-vs-Asian |
6.067000E-01 |
| Caucasian-vs-AfricanAmerican |
1.54838999999463E-05 |
| Caucasian-vs-Asian |
8.751200E-01 |
| AfricanAmerican-vs-Asian |
1.239600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.840500E-02 |
| Normal-vs-Female |
9.884800E-01 |
| Male-vs-Female |
2.930000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.578460E-02 |
| Normal-vs-Age(41-60Yrs) |
5.383600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.474580E-01 |
| Normal-vs-Age(81-100Yrs) |
3.565400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.066560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.797040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.172200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.573600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.743800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.996200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.598600E-01 |
| Normal-vs-Grade 2 |
9.650800E-01 |
| Normal-vs-Grade 3 |
7.597800E-02 |
| Normal-vs-Grade 4 |
7.000700E-03 |
| Grade 1-vs-Grade 2 |
5.860800E-01 |
| Grade 1-vs-Grade 3 |
1.803240E-01 |
| Grade 1-vs-Grade 4 |
5.480500E-02 |
| Grade 2-vs-Grade 3 |
4.239500E-02 |
| Grade 2-vs-Grade 4 |
4.818600E-03 |
| Grade 3-vs-Grade 4 |
1.389420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.710400E-01 |
| Normal-vs-ccB subtype |
2.396600E-01 |
| ccA subtype-vs-ccB subtype |
2.925800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.268200E-01 |
| Normal-vs-N1 |
6.478600E-01 |
| N0-vs-N1 |
7.330600E-01 |
|
|
